文献速递心脑血管急症消化、代谢与肾脏急症

七种流行结构化饮食方案对心血管高危人群死亡和主要心血管事件风险的比较:系统评价与网状Meta分析

Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis.
PubMed 文献 · BMJ · 2023-03-29
一句话结论中等确定性证据显示,地中海饮食和低脂饮食方案可降低心血管高危患者全因死亡和非致死性心肌梗死,地中海饮食还可能降低卒中风险。

该系统评价与网状Meta分析纳入40项随机对照试验、共35548名心血管高危患者,比较七种具名饮食方案与最小干预或替代方案的效果。基于中等确定性证据,地中海饮食方案较最小干预降低全因死亡(OR 0.72,95%CI 0.56-0.92)、心血管死亡(OR 0.55,95%CI 0.39-0.78)、卒中(OR 0.65,95%CI 0.46-0.93)和非致死性心肌梗死(OR 0.48,95%CI 0.36-0.65);低脂方案降低全因死亡(OR 0.84,95%CI 0.74-0.95)和非致死性心肌梗死(OR 0.77,95%CI 0.61-0.96)。两种方案绝对效应在高危患者中更明显,其余五种方案较最小干预一般无优势。

要点

  • 地中海饮食方案较最小干预降低全因死亡(OR 0.72,95%CI 0.56-0.92;中危患者5年每1000人减少17例)和心血管死亡(OR 0.55,95%CI 0.39-0.78;每1000人减少13例)。
  • 地中海饮食方案还降低卒中(OR 0.65,95%CI 0.46-0.93;每1000人减少7例)和非致死性心肌梗死(OR 0.48,95%CI 0.36-0.65;每1000人减少17例)。
  • 低脂饮食方案较最小干预降低全因死亡(OR 0.84,95%CI 0.74-0.95;每1000人减少9例)和非致死性心肌梗死(OR 0.77,95%CI 0.61-0.96;每1000人减少7例)。
  • 地中海饮食与低脂饮食方案在死亡或非致死性心肌梗死方面无令人信服的差异。
  • 其余五种方案(极低脂、改良脂肪、低脂联合低钠、Ornish、Pritikin)较最小干预一般益处很小或无益处,证据确定性多为低至中等。

适用人群与场景

  • 心血管疾病风险增加的患者,来自比较饮食方案与最小干预或替代方案的随机对照试验,随访至少9个月。
  • 饮食方案除饮食干预外,还可包括运动、行为支持及药物治疗等其他辅助干预。

研究设计与关键结果

  • 系统评价与网状Meta分析纳入40项随机对照试验、35548名参与者,涉及七种具名饮食方案:低脂(18项研究)、地中海(12项)、极低脂(6项)、改良脂肪(4项)、低脂联合低钠(3项)、Ornish(3项)、Pritikin(1项)。
  • 地中海饮食方案较最小干预:全因死亡OR 0.72(95%CI 0.56-0.92;中危患者5年每1000人减少17例)、心血管死亡OR 0.55(95%CI 0.39-0.78;每1000人减少13例)、卒中OR 0.65(95%CI 0.46-0.93;每1000人减少7例)、非致死性心肌梗死OR 0.48(95%CI 0.36-0.65;每1000人减少17例),基于中等确定性证据。
  • 低脂饮食方案较最小干预:全因死亡OR 0.84(95%CI 0.74-0.95;每1000人减少9例)、非致死性心肌梗死OR 0.77(95%CI 0.61-0.96;每1000人减少7例),基于中等确定性证据。
  • 两种饮食方案的绝对效应在高危患者中更明显。
  • 地中海饮食与低脂饮食方案在死亡或非致死性心肌梗死方面无令人信服的差异。
  • 其余五种饮食方案较最小干预一般益处很小或无益处,证据确定性多为低至中等。

证据类型、等级与局限

  • 证据类型:系统评价与随机对照试验的网状Meta分析。
  • 采用GRADE方法评价每个结局的证据确定性;地中海饮食和低脂饮食方案的关键结局基于中等确定性证据。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,促进地中海饮食和低脂饮食的方案(联合或不联合体力活动或其他干预)可降低心血管高危患者的全因死亡和非致死性心肌梗死。
  • 作者认为,地中海饮食方案还可能降低卒中风险。
  • 作者认为,其他具名饮食方案一般并不优于最小干预。

指南或共识出处

  • PROSPERO注册号CRD42016047939。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To determine the relative efficacy of structured named diet and health behaviour programmes (dietary programmes) for prevention of mortality and major cardiovascular events in patients at increased risk of cardiovascular disease.

DESIGN: Systematic review and network meta-analysis of randomised controlled trials.

DATA SOURCES: AMED (Allied and Complementary Medicine Database), CENTRAL (Cochrane Central Register of Controlled Trials), Embase, Medline, CINAHL (Cumulative Index to Nursing and Allied Health Literature), and ClinicalTrials.gov were searched up to September 2021.

STUDY SELECTION: Randomised trials of patients at increased risk of cardiovascular disease that compared dietary programmes with minimal intervention (eg, healthy diet brochure) or alternative programmes with at least nine months of follow-up and reporting on mortality or major cardiovascular events (such as stroke or non-fatal myocardial infarction). In addition to dietary intervention, dietary programmes could also include exercise, behavioural support, and other secondary interventions such as drug treatment.

OUTCOMES AND MEASURES: All cause mortality, cardiovascular mortality, and individual cardiovascular events (stroke, non-fatal myocardial infarction, and unplanned cardiovascular interventions).

REVIEW METHODS: Pairs of reviewers independently extracted data and assessed risk of bias. A random effects network meta-analysis was performed using a frequentist approach and grading of recommendations assessment, development and evaluation (GRADE) methods to determine the certainty of evidence for each outcome.

RESULTS: 40 eligible trials were identified with 35 548 participants across seven named dietary programmes (low fat, 18 studies; Mediterranean, 12; very low fat, 6; modified fat, 4; combined low fat and low sodium, 3; Ornish, 3; Pritikin, 1). At last reported follow-up, based on moderate certainty evidence, Mediterranean dietary programmes proved superior to minimal intervention for the prevention of all cause mortality (odds ratio 0.72, 95% confidence interval 0.56 to 0.92; patients at intermediate risk: risk difference 17 fewer per 1000 followed over five years), cardiovascular mortality (0.55, 0.39 to 0.78; 13 fewer per 1000), stroke (0.65, 0.46 to 0.93; 7 fewer per 1000), and non-fatal myocardial infarction (0.48, 0.36 to 0.65; 17 fewer per 1000). Based on moderate certainty evidence, low fat programmes proved superior to minimal intervention for prevention of all cause mortality (0.84, 0.74 to 0.95; 9 fewer per 1000) and non-fatal myocardial infarction (0.77, 0.61 to 0.96; 7 fewer per 1000). The absolute effects for both dietary programmes were more pronounced for patients at high risk. There were no convincing differences between Mediterranean and low fat programmes for mortality or non-fatal myocardial infarction. The five remaining dietary programmes generally had little or no benefit compared with minimal intervention typically based on low to moderate certainty evidence.

CONCLUSIONS: Moderate certainty evidence shows that programmes promoting Mediterranean and low fat diets, with or without physical activity or other interventions, reduce all cause mortality and non-fatal myocardial infarction in patients with increased cardiovascular risk. Mediterranean programmes are also likely to reduce stroke risk. Generally, other named dietary programmes were not superior to minimal intervention.

SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42016047939.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Karam G, Agarwal A, Sadeghirad B, et al. Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis. BMJ. 2023. PMID: 36990505. doi:10.1136/bmj-2022-072003

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。